Skip to content

Silicon Laboratories SLAB Other long-term liabilities

Other long-term liabilities at other companies

MaxLinear logo
MaxLinearMXL

Other financials

Income statement

See full
Revenue$213.5M+20.1%
Gross profit$127.0M+29.9%
Operating income-$17.1M+46.8%
Net income-$15.9M+47.8%
EPS (diluted)-$0.48+48.9%

Balance sheet

See full
Cash & equivalents$383.1M+17.9%
Total debt$24.0M+11.8%
Total equity$1.1B+2.8%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$4.9M-89.7%
CapEx$9.8M+103%
Free cash flow-$4.9M-111%

Valuation

See full
Market cap$7.25B+113%
P/S8.8×+3.6×

Profitability

See full
Gross margin59.3%+5.1pp
Operating margin-6.8%-2.7pp
Net margin-6.1%-2.6pp
FCF margin-6.3%-21.8pp

Returns & leverage

See full
Return on equity-4.6%-1.9pp
Debt / equity0.0×
Current ratio5.1×-0.1×

Where this comes from

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Silicon Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Silicon Laboratories's other long-term liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Silicon Laboratories's other long-term liabilities?
Silicon Laboratories (SLAB) reported other long-term liabilities of $3.26M in Q1 2026.
How has Silicon Laboratories's other long-term liabilities changed year-over-year?
Silicon Laboratories's other long-term liabilities increased by 199.3% year-over-year, from -$3.28M to $3.26M.
What is the long-term trend for Silicon Laboratories's other long-term liabilities?
Over 4 years (2021 to 2025), Silicon Laboratories's other long-term liabilities has grown at a -3.1% compound annual growth rate (CAGR), from -$14.6M to -$12.86M.